Last reviewed · How we verify
Human Umbilical Cord Blood Plasma
Human Umbilical Cord Blood Plasma is a Biologic drug developed by Hexagon Therapies, LLC. It is currently in Phase 1 development.
At a glance
| Generic name | Human Umbilical Cord Blood Plasma |
|---|---|
| Sponsor | Hexagon Therapies, LLC |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain (PHASE1)
- Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (PHASE1, PHASE2)
- Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury (PHASE1, PHASE2)
- UCB Stem Cells for Autism Spectrum Disorders (PHASE1)
- Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline (PHASE1)
- A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM) (PHASE1)
- Quality of Life Improvements With Cord Blood Plasma (PHASE1)
- UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Human Umbilical Cord Blood Plasma CI brief — competitive landscape report
- Human Umbilical Cord Blood Plasma updates RSS · CI watch RSS
- Hexagon Therapies, LLC portfolio CI
Frequently asked questions about Human Umbilical Cord Blood Plasma
What is Human Umbilical Cord Blood Plasma?
Human Umbilical Cord Blood Plasma is a Biologic drug developed by Hexagon Therapies, LLC.
Who makes Human Umbilical Cord Blood Plasma?
Human Umbilical Cord Blood Plasma is developed by Hexagon Therapies, LLC (see full Hexagon Therapies, LLC pipeline at /company/hexagon-therapies-llc).
What development phase is Human Umbilical Cord Blood Plasma in?
Human Umbilical Cord Blood Plasma is in Phase 1.
Related
- Manufacturer: Hexagon Therapies, LLC — full pipeline